JTC Employer Solutions Trustee Ltd Sells 69,580 Shares of Haleon plc (NYSE:HLN)

JTC Employer Solutions Trustee Ltd reduced its stake in shares of Haleon plc (NYSE:HLN) by 64.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,569 shares of the company’s stock after selling 69,580 shares during the period. JTC Employer Solutions Trustee Ltd’s holdings in Haleon were worth $367,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of HLN. AE Wealth Management LLC increased its stake in shares of Haleon by 6.1% in the second quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock worth $159,000 after purchasing an additional 1,098 shares during the period. Lake Street Advisors Group LLC increased its stake in shares of Haleon by 5.4% in the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock worth $237,000 after purchasing an additional 1,143 shares during the period. Synovus Financial Corp increased its stake in shares of Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after purchasing an additional 1,216 shares during the period. Hexagon Capital Partners LLC increased its stake in shares of Haleon by 18.5% in the third quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after purchasing an additional 1,238 shares during the period. Finally, Brown Brothers Harriman & Co. increased its stake in shares of Haleon by 21.4% in the second quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock worth $63,000 after purchasing an additional 1,334 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Haleon Price Performance

NYSE HLN traded down $0.08 during trading on Monday, reaching $9.02. 3,539,394 shares of the company traded hands, compared to its average volume of 7,724,963. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock’s 50 day moving average price is $9.59 and its two-hundred day moving average price is $9.69. The company has a market cap of $40.83 billion, a price-to-earnings ratio of 26.53, a P/E/G ratio of 2.95 and a beta of 0.29. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HLN shares. UBS Group raised Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday. Finally, Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.